Option Care Health, Inc. (NASDAQ:OPCH) Receives $35.50 Consensus PT from Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) have been given an average rating of "Moderate Buy" by the eight analysts that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $35.50.

OPCH has been the subject of a number of research reports. JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday, April 30th. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, JMP Securities reissued a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research report on Tuesday, April 22nd.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.64% of the company's stock.

Institutional Investors Weigh In On Option Care Health

Large investors have recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio boosted its holdings in shares of Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after acquiring an additional 332 shares during the period. Cornerstone Investment Partners LLC lifted its position in Option Care Health by 3.6% in the 4th quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company's stock valued at $221,000 after purchasing an additional 333 shares during the last quarter. UMB Bank n.a. lifted its position in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares during the last quarter. US Bancorp DE boosted its stake in Option Care Health by 5.0% during the 1st quarter. US Bancorp DE now owns 8,199 shares of the company's stock valued at $287,000 after purchasing an additional 393 shares during the period. Finally, Assetmark Inc. grew its position in Option Care Health by 2.0% in the 4th quarter. Assetmark Inc. now owns 24,976 shares of the company's stock worth $579,000 after purchasing an additional 487 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Stock Down 1.2%

Option Care Health stock traded down $0.38 during midday trading on Friday, hitting $31.74. 881,761 shares of the stock were exchanged, compared to its average volume of 1,858,425. Option Care Health has a 1 year low of $21.39 and a 1 year high of $35.53. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market cap of $5.20 billion, a P/E ratio of 26.67, a P/E/G ratio of 2.30 and a beta of 0.76. The company has a 50 day moving average price of $32.83 and a two-hundred day moving average price of $29.48.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.36 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The business's revenue was up 16.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.26 EPS. On average, sell-side analysts predict that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.